Technical Intelligence & Insights
Explore our curated collection of technical analyses and commercial scale-up strategies specifically focused on Catalysis. These insights are designed to support R&D and procurement teams in optimizing their supply chains.
Patent CN102040625B discloses efficient chiral spiro ligands for iridium-catalyzed asymmetric hydrogenation, offering high enantioselectivity and low catalyst loading for pharmaceutical manufacturing.
Patent CN101914595A reveals enzymatic route for ferulic acid sugar esters offering green manufacturing advantages and supply chain stability for global pharmaceutical intermediates procurement.
Novel nickel-copper catalytic synthesis offers high yield and scalability for pharmaceutical intermediates, ensuring supply chain stability and cost efficiency.
Patent CN118272464A reveals enzymatic synthesis of alpha-hydroxystearic acid. Offers green, high-yield production for reliable ceramide precursor supply chains.
Discover the advanced enantioselective process for HMG-CoA inhibitors described in CN1636004A. Achieve high purity statin intermediates with reduced waste and scalable catalytic methods.
Patent CN105801342A reveals high-yield phenanthrene synthesis using Pd-Cu catalysts. Offers cost reduction and supply chain reliability for pharmaceutical intermediate manufacturing.
Patent CN102020562B reveals a green solid base catalytic route for Antioxidant 1076, offering high purity and recyclable catalysts for polymer additive manufacturing.
Patent CN110240551B reveals a high-yield catalytic route for Fmoc-beta-Ala-Gly-OH, offering superior purity and cost efficiency for peptide manufacturing.
Novel Ni-catalyzed route for chiral nafoxidine-3-carboxylic acid. Enhances purity and supply chain reliability for pharmaceutical intermediates manufacturing globally.
Novel immobilized enzyme method for ATP production ensures high purity and stable supply chain for pharmaceutical intermediates manufacturing globally.
Patent CN111635435A reveals a stable copper catalyst for synthesizing beta-carbonylphosphine oxides. Enables cost reduction in fine chemical manufacturing via mild conditions.
Patent CN104711299B reveals enzymatic adrenaline synthesis. High purity, lower cost, and scalable supply chain solutions for pharmaceutical intermediates manufacturing.
Patent CN115215835A reveals a high-yield two-step Negishi coupling route for isoindoline intermediates, offering significant cost and safety advantages for API manufacturing.
Patent CN109879847B reveals a scalable base-catalyzed deuteration method for flavonoids like baicalein and quercetin, offering improved metabolic stability for API development.
Patent CN101948405B reveals a mild FeCl3-catalyzed bromination method for aryl azides, offering cost reduction in API manufacturing and scalable production.
Patent CN103193720B reveals a high-yield Pirimicarb method using NaOH and DMAP. This process ensures cost reduction and supply chain reliability for manufacturers.
Patent CN107188781B details a mild cyclization method for isopulegol with high enantioselectivity, offering cost-effective manufacturing solutions for menthol intermediates.
Patent CN111363736A reveals a novel enzymatic route for dexketoprofen using Klebsiella amidase, offering superior ee values and greener manufacturing for pharmaceutical intermediates.
Patent CN102719378A reveals high-purity (-)-gamma-lactam production via Delftia sp., offering cost-effective API manufacturing solutions.
Patent CN116178243A reveals a mild visible-light photocatalytic method for carbazole synthesis, offering significant cost reduction and high purity for pharmaceutical intermediates manufacturing.